GCG and type 2 diabetes mellitus: In condition with impaired insulin secretion such as in insulin-dependent type 1 and type 2 diabetes mellitus (T2DM), the MMTT is used to assess β-cell function and is regarded as more physiological than the glucagon stimulation test (GST), which is a standard measure of endogenous insulin secretion2–4.